A

Alpha Cognition Inc
NASDAQ:ACOG

Watchlist Manager
Alpha Cognition Inc
NASDAQ:ACOG
Watchlist
Price: 9.105 USD -1.14%
Market Cap: 145.9m USD

Relative Value

There is not enough data to reliably calculate the relative value of ACOG.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ACOG Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.1
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.4
Industry
22.9
vs History
vs Industry
Median 3Y
-0.8
Median 5Y
-0.8
Industry
19.4
vs History
vs Industry
Median 3Y
-0.8
Median 5Y
-0.8
Industry
22.6
vs History
vs Industry
Median 3Y
5.5
Median 5Y
5.3
Industry
2.7
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.2
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.4
Industry
4.5
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.4
Industry
4.5
vs History
vs Industry
Median 3Y
-0.5
Median 5Y
-0.5
Industry
5
vs History
vs Industry
Median 3Y
-0.5
Median 5Y
-0.5
Industry
3.7
vs History
vs Industry
Median 3Y
-16.6
Median 5Y
-17
Industry
4.9

Multiples Across Competitors

ACOG Competitors Multiples
Alpha Cognition Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Alpha Cognition Inc
NASDAQ:ACOG
9.9m USD 0 -0.4 -0.4 -0.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 829 747 -160 787.8 -195 247.6 -193 019.6
US
Abbvie Inc
NYSE:ABBV
325.7B USD 5.7 78.9 15.1 22.3
US
Amgen Inc
NASDAQ:AMGN
149.7B USD 4.4 25.3 13.8 22.7
US
Gilead Sciences Inc
NASDAQ:GILD
137.7B USD 4.8 23 10 13.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.1B USD 10.3 -115.5 24.5 25.7
US
Epizyme Inc
F:EPE
94.1B EUR 2 082.5 -531.4 -578.6 -563.2
AU
CSL Ltd
ASX:CSL
116B AUD 5 27.6 17 21.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
56.5B USD 4 12.5 11.1 12.5
US
Seagen Inc
F:SGT
39.3B EUR 20.1 -61.5 -66.3 -59.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
42.1B USD 18.1 -157.2 -705.6 -353.6
P/S Multiple
Revenue Growth P/S to Growth
CA
A
Alpha Cognition Inc
NASDAQ:ACOG
Average P/S: 3 383 190.2
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 829 747
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.7
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.4
4%
1.1
US
Gilead Sciences Inc
NASDAQ:GILD
4.8
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.3
10%
1
US
E
Epizyme Inc
F:EPE
2 082.5
N/A N/A
AU
CSL Ltd
ASX:CSL
5
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4
4%
1
US
S
Seagen Inc
F:SGT
20.1
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
18.1
29%
0.6
P/E Multiple
Earnings Growth PEG
CA
A
Alpha Cognition Inc
NASDAQ:ACOG
Average P/E: 33.5
Negative Multiple: -0.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 787.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
78.9
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
25.3
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -115.5 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.4 N/A N/A
AU
CSL Ltd
ASX:CSL
27.6
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.5
7%
1.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.5 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -157.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
A
Alpha Cognition Inc
NASDAQ:ACOG
Average EV/EBITDA: 15.3
Negative Multiple: -0.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 247.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.1
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
13.8
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.5
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -578.6 N/A N/A
AU
CSL Ltd
ASX:CSL
17
11%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.1
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -705.6 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
A
Alpha Cognition Inc
NASDAQ:ACOG
Average EV/EBIT: 19.7
Negative Multiple: -0.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 019.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.3
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
22.7
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.8
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.7
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.2 N/A N/A
AU
CSL Ltd
ASX:CSL
21.3
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.5
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.8 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -353.6 N/A N/A